Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06481111

Enrollment

1000

Registered

2024-07-01

Start date

2024-07-10

Completion date

2034-12-01

Last updated

2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypovitaminosis D

Brief summary

The Endocrinology Unit of the IRCCS San Raffaele Hospital is dedicated to establishing a prospective single-center registry with data from patients undergoing vitamin D supplementation, initiating their first visit to the outpatient unit until December 2029. 1000 patients will be enrolled, aligning with the unit's recent patient influx for hypovitaminosis D. The registry's goal is to assess the epidemiological trend, identify risk factors, and evaluate the diagnostic and therapeutic clinical management strategies for hypovitaminosis D. It will involve collecting clinical, laboratory, and historical data during outpatient visits, adhering to the standard diagnostic and therapeutic protocols for endocrine-metabolic diseases. This data collection is expected to continue for a duration of ten years.

Interventions

DRUGsupplementary treatment with vitamin D

observational design

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adult men and women (age ≥ 18 years) regardless of fertility status and pregnancy/breastfeeding conditions * Vitamin D supplementation, with any formulation and dosage * Signing of informed consent

Exclusion criteria

* Patients unable to understand and sign informed consent.

Design outcomes

Primary

Measure	Time frame	Description
Change from baseline of data in outpatient accessing Endocrinology Unit of the IRCCS San Raffaele Hospital for endocrine-metabolic diseases who are on supplementary treatment with vitamin D.	10 years	The main outcome of the study is to assess the prevalence changes of major comorbidities and their complications including cardiovascular diseases, diabetes, cancer, and osteoporosis, during the study-period in relation to the use and characteristics of vitamin D supplementation, in order to evaluate the potential influence of vitamin D use on patient's outcomes. The pathological conditions will be diagnosed according to current major guidelines and clinical practice.

Countries

Italy

Contacts

CONTACTLuigi Di Filippo, MD

difilippo.luigi@hsr.it+39022643

CONTACTEndocrinology Trial Office, CRN

trials.endocrinologia@hsr.it022643

PRINCIPAL_INVESTIGATORLuigi di Filippo, MD

IRCCS San Raffaele

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026